Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Why Kenya, Ethiopia, Japan, and the US stand out in global distance running

26

May 2026

Why Kenya, Ethiopia, Japan, and the US stand out in global distance running

This global analysis of 152,943 endurance runners found that nationality, gender, age, and race distance were significantly associated with running performance from 1999 to 2024. Men were faster across all distances, women were generally older in longer races, and runners from Kenya, Ethiopia, Japan, and the United States showed distinct participation and performance patterns.

How a tiny H5N1 dose triggers massive virus shedding in cow milk

25

May 2026

How a tiny H5N1 dose triggers massive virus shedding in cow milk

Experimental infection studies in lactating Holstein cows showed that H5N1 B3.13 can infect the bovine mammary gland at doses as low as 10 TCID50, producing extremely high viral loads in milk. However, the virus did not transmit to sentinel cows through repeated exposure to contaminated milking equipment or through close contact under high-biocontainment conditions, suggesting that real-world dairy-farm spread depends on additional cofactors.

Ongoing nausea in pregnancy may flag anxiety and depression risk

25

May 2026

Ongoing nausea in pregnancy may flag anxiety and depression risk

Persistent or severe nausea during pregnancy was linked to higher maternal anxiety and depressive symptoms across gestation. The study found little consistent evidence that nausea worsened most perinatal outcomes, suggesting it may serve mainly as a clinical warning sign for psychological burden.

Diet and inflammation may play a role in progressive vitiligo

25

May 2026

Diet and inflammation may play a role in progressive vitiligo

A small case-control study linked higher Dietary Inflammatory Index scores with progressive vitiligo, suggesting that pro-inflammatory dietary patterns may be associated with disease occurrence or progression. The findings support further research into diet, inflammation, and the gut-skin axis as potential targets for vitiligo prevention and management.

Chronic liver disease threatens millions across Europe, report finds

25

May 2026

Chronic liver disease threatens millions across Europe, report finds

Europe is facing a growing chronic liver disease threat, according to a new Series published today in The Lancet Regional Health – Europe, that engaged more than 75 co-authors from 30 countries and was led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.